Corient Private Wealth
HRMY icon

Corient Private Wealth’s Harmony Biosciences HRMY Stock Holding History

Corient Private Wealth’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$411K Buy
+11,294
New +$356K ﹤0.01% 2366
2023
Q2 		– Sell
-283,322
Closed -$9.25M – 2114
2023
Q1 		$9.25M Buy
283,322
+73,907
+35% +$3.37M 0.02% 445
2022
Q4 		$11.5M Buy
+209,415
New +$11.5M 0.04% 346

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Corient Private Wealth's HRMY Position: Q2 2026 in Review

Corient Private Wealth opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 11,294 shares worth $411K. The stake represents ﹤0.01% of the portfolio and ranks #2366 among its holdings. This is a return to the name: Corient Private Wealth previously reported a position in HRMY as recently as Q1 2023.

Corient Private Wealth first reported a position in HRMY in Q4 2022 and has held it in 3 quarters since. The position peaked at $11.5M in Q4 2022. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Corient Private Wealth held 11,294 shares of Harmony Biosciences worth $411K as of Q2 2026.
  • Harmony Biosciences was a new Corient Private Wealth position in Q2 2026.
  • Harmony Biosciences made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2366 holding.
  • Corient Private Wealth first reported a position in Harmony Biosciences in Q4 2022 and has held it in 3 quarters since.
  • Corient Private Wealth's Harmony Biosciences position peaked at $11.5M in Q4 2022.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.